美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70377-091-23	70377-091	HUMAN PRESCRIPTION DRUG	Everolimus	Everolimus	TABLET, FOR SUSPENSION	ORAL	20260114	N/A	ANDA	ANDA217216	Biocon Pharma Inc.	EVEROLIMUS	3 mg/1	4 BLISTER PACK in 1 CARTON (70377-091-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK
70377-092-11	70377-092	HUMAN PRESCRIPTION DRUG	Everolimus	Everolimus	TABLET, FOR SUSPENSION	ORAL	20260114	N/A	ANDA	ANDA217216	Biocon Pharma Inc.	EVEROLIMUS	5 mg/1	28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-092-11)
70377-092-23	70377-092	HUMAN PRESCRIPTION DRUG	Everolimus	Everolimus	TABLET, FOR SUSPENSION	ORAL	20260114	N/A	ANDA	ANDA217216	Biocon Pharma Inc.	EVEROLIMUS	5 mg/1	4 BLISTER PACK in 1 CARTON (70377-092-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK
70377-091-11	70377-091	HUMAN PRESCRIPTION DRUG	Everolimus	Everolimus	TABLET, FOR SUSPENSION	ORAL	20260114	N/A	ANDA	ANDA217216	Biocon Pharma Inc.	EVEROLIMUS	3 mg/1	28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-091-11)
70377-090-23	70377-090	HUMAN PRESCRIPTION DRUG	Everolimus	Everolimus	TABLET, FOR SUSPENSION	ORAL	20260114	N/A	ANDA	ANDA217216	Biocon Pharma Inc.	EVEROLIMUS	2 mg/1	4 BLISTER PACK in 1 CARTON (70377-090-23) / 7 TABLET, FOR SUSPENSION in 1 BLISTER PACK
70377-090-11	70377-090	HUMAN PRESCRIPTION DRUG	Everolimus	Everolimus	TABLET, FOR SUSPENSION	ORAL	20260114	N/A	ANDA	ANDA217216	Biocon Pharma Inc.	EVEROLIMUS	2 mg/1	28 TABLET, FOR SUSPENSION in 1 BOTTLE (70377-090-11)